Empower Advisory Group LLC Has $294,000 Position in Corteva, Inc. (NYSE:CTVA)

Empower Advisory Group LLC lifted its stake in shares of Corteva, Inc. (NYSE:CTVA) by 10.3% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 4,998 shares of the company’s stock after acquiring an additional 468 shares during the period. Empower Advisory Group LLC’s holdings in Corteva were worth $294,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of CTVA. Capital International Investors raised its holdings in Corteva by 2.6% during the first quarter. Capital International Investors now owns 26,437,457 shares of the company’s stock worth $1,524,648,000 after buying an additional 678,722 shares during the last quarter. Van ECK Associates Corp raised its holdings in Corteva by 2.5% during the third quarter. Van ECK Associates Corp now owns 8,902,675 shares of the company’s stock worth $541,194,000 after buying an additional 213,872 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in Corteva by 28.4% during the second quarter. Bank of New York Mellon Corp now owns 6,842,907 shares of the company’s stock worth $369,106,000 after buying an additional 1,514,954 shares during the last quarter. Legal & General Group Plc raised its holdings in shares of Corteva by 0.9% in the second quarter. Legal & General Group Plc now owns 6,741,972 shares of the company’s stock valued at $363,662,000 after purchasing an additional 61,127 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in shares of Corteva by 5.1% during the second quarter. Dimensional Fund Advisors LP now owns 4,649,450 shares of the company’s stock valued at $250,786,000 after purchasing an additional 224,423 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Price Performance

Shares of NYSE CTVA opened at $55.19 on Friday. The stock has a market cap of $37.93 billion, a PE ratio of 55.74, a price-to-earnings-growth ratio of 1.85 and a beta of 0.77. Corteva, Inc. has a fifty-two week low of $43.89 and a fifty-two week high of $63.75. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.96 and a current ratio of 1.50. The stock has a fifty day moving average of $58.34 and a 200-day moving average of $55.67.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Monday, December 2nd will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.23%. The ex-dividend date is Monday, December 2nd. Corteva’s dividend payout ratio (DPR) is presently 68.69%.

Wall Street Analyst Weigh In

CTVA has been the subject of a number of recent analyst reports. Morgan Stanley reaffirmed an “overweight” rating and issued a $65.00 price objective on shares of Corteva in a research report on Tuesday, September 24th. UBS Group lifted their price target on Corteva from $67.00 to $71.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. Barclays raised their target price on Corteva from $58.00 to $62.00 and gave the company an “equal weight” rating in a research report on Friday, November 8th. KeyCorp cut their price target on shares of Corteva from $66.00 to $62.00 and set an “overweight” rating on the stock in a report on Friday, August 2nd. Finally, Wells Fargo & Company decreased their price objective on shares of Corteva from $67.00 to $65.00 and set an “overweight” rating for the company in a report on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $63.68.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.